Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow transplantation for genetic diseases.

C Lenarsky1, D B Kohn, K I Weinberg

  • 1University of Southern California School of Medicine.

Hematology/Oncology Clinics of North America
|June 1, 1990
PubMed
Summary

Bone marrow transplantation effectively treats genetic diseases, including blood disorders like thalassemia and sickle cell anemia. This success paves the way for gene therapy applications in treating inherited conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The treatment of adenosine deaminase deficiency.

Immunology today·2014
Same author

Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector.

Gene therapy·2010
Same author

Study of thymic size and function in children and adolescents with treatment refractory systemic sclerosis eligible for immunoablative therapy.

Clinical immunology (Orlando, Fla.)·2009
Same author

Lentiviral vectors with amplified beta cell-specific gene expression.

Gene therapy·2009
Same author

Tissue-specific restriction of cyclophilin A-independent HIV-1- and SIV-derived lentiviral vectors.

Gene therapy·2008
Same author

Gene therapy for childhood immunological diseases.

Bone marrow transplantation·2007

Area of Science:

  • Hematology
  • Genetics
  • Transplantation Medicine

Background:

  • Bone marrow transplantation (BMT) is a primary treatment for various genetic disorders.
  • The application of BMT is expanding to include erythroid disorders such as thalassemia and sickle cell anemia.
  • Inherited metabolic disorders, including storage diseases and leukodystrophies, can be corrected through marrow transplantation.

Purpose of the Study:

  • To highlight the efficacy of bone marrow transplantation in treating genetic diseases.
  • To discuss the expanding role of BMT in hematological and metabolic disorders.
  • To establish the foundation for gene therapy based on successful BMT outcomes.

Main Methods:

  • Review of current clinical practices and outcomes in bone marrow transplantation.

Related Experiment Videos

  • Analysis of BMT effectiveness for genetic, erythroid, and metabolic disorders.
  • Evaluation of the implications of successful allogeneic BMT for future gene therapy development.

    • Main Results:

    • Bone marrow transplantation is established as a curative treatment for numerous genetic diseases.
    • BMT shows increasing success in managing thalassemia and sickle cell anemia.
    • Inherited metabolic conditions are demonstrably correctable via marrow transplantation.

    Conclusions:

    • Allogeneic bone marrow transplantation offers a viable treatment for a range of genetic disorders.
    • The success of BMT in genetic disease correction supports its use in erythroid and metabolic conditions.
    • Successful BMT outcomes provide a critical basis for advancing specific gene therapy strategies.